GO:0003723 | RNA binding | 3.56e-07 | 3.48e-03 | 3.790 | 7 | 22 | 247 |
GO:0008380 | RNA splicing | 6.77e-07 | 6.61e-03 | 4.150 | 6 | 21 | 165 |
GO:0005654 | nucleoplasm | 2.57e-06 | 2.51e-02 | 2.479 | 10 | 68 | 876 |
GO:0000398 | mRNA splicing, via spliceosome | 4.74e-06 | 4.63e-02 | 4.253 | 5 | 15 | 128 |
GO:0010467 | gene expression | 5.40e-06 | 5.27e-02 | 2.868 | 8 | 49 | 535 |
GO:0030529 | ribonucleoprotein complex | 2.02e-05 | 1.97e-01 | 4.574 | 4 | 5 | 82 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.97e-05 | 3.88e-01 | 7.610 | 2 | 2 | 5 |
GO:0070937 | CRD-mediated mRNA stability complex | 5.95e-05 | 5.81e-01 | 7.347 | 2 | 2 | 6 |
GO:0044822 | poly(A) RNA binding | 1.00e-04 | 9.80e-01 | 2.289 | 8 | 45 | 799 |
GO:0005515 | protein binding | 1.06e-04 | 1.00e+00 | 1.009 | 17 | 198 | 4124 |
GO:0006379 | mRNA cleavage | 1.42e-04 | 1.00e+00 | 6.762 | 2 | 2 | 9 |
GO:0001649 | osteoblast differentiation | 4.34e-04 | 1.00e+00 | 4.307 | 3 | 5 | 74 |
GO:0007049 | cell cycle | 1.57e-03 | 1.00e+00 | 3.671 | 3 | 8 | 115 |
GO:0004832 | valine-tRNA ligase activity | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:0016149 | translation release factor activity, codon specific | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 1 |
GO:0031124 | mRNA 3'-end processing | 2.28e-03 | 1.00e+00 | 4.802 | 2 | 4 | 35 |
GO:0006369 | termination of RNA polymerase II transcription | 2.68e-03 | 1.00e+00 | 4.684 | 2 | 5 | 38 |
GO:0044212 | transcription regulatory region DNA binding | 2.92e-03 | 1.00e+00 | 3.357 | 3 | 13 | 143 |
GO:0006396 | RNA processing | 2.97e-03 | 1.00e+00 | 4.610 | 2 | 4 | 40 |
GO:0006406 | mRNA export from nucleus | 3.58e-03 | 1.00e+00 | 4.472 | 2 | 7 | 44 |
GO:0048742 | regulation of skeletal muscle fiber development | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:0003747 | translation release factor activity | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 2 | 2 |
GO:0005846 | nuclear cap binding complex | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:2000781 | positive regulation of double-strand break repair | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 2 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.54e-03 | 1.00e+00 | 2.518 | 4 | 23 | 341 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.97e-03 | 1.00e+00 | 4.231 | 2 | 8 | 52 |
GO:0000166 | nucleotide binding | 5.24e-03 | 1.00e+00 | 3.057 | 3 | 13 | 176 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 3 |
GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 3 |
GO:0046914 | transition metal ion binding | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 3 |
GO:0070006 | metalloaminopeptidase activity | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 3 |
GO:0042826 | histone deacetylase binding | 6.15e-03 | 1.00e+00 | 4.073 | 2 | 5 | 58 |
GO:0071013 | catalytic step 2 spliceosome | 6.78e-03 | 1.00e+00 | 4.001 | 2 | 5 | 61 |
GO:0006281 | DNA repair | 7.77e-03 | 1.00e+00 | 2.851 | 3 | 24 | 203 |
GO:0045292 | mRNA cis splicing, via spliceosome | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0097452 | GAIT complex | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 2 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 2 | 4 |
GO:0006449 | regulation of translational termination | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0007000 | nucleolus organization | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0071156 | regulation of cell cycle arrest | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 2 | 4 |
GO:0010815 | bradykinin catabolic process | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 4 |
GO:0004521 | endoribonuclease activity | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 5 |
GO:0090344 | negative regulation of cell aging | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 5 |
GO:0005672 | transcription factor TFIIA complex | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 5 |
GO:0006282 | regulation of DNA repair | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 2 | 5 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 5 |
GO:0042382 | paraspeckles | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 3 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 6 |
GO:0046578 | regulation of Ras protein signal transduction | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 6 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.26e-02 | 1.00e+00 | 3.539 | 2 | 5 | 84 |
GO:0002199 | zona pellucida receptor complex | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 4 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 7 |
GO:0008409 | 5'-3' exonuclease activity | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 7 |
GO:0007617 | mating behavior | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 7 |
GO:0000339 | RNA cap binding | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 4 | 7 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 7 |
GO:0005845 | mRNA cap binding complex | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0006878 | cellular copper ion homeostasis | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 4 | 8 |
GO:0010225 | response to UV-C | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 3 | 9 |
GO:0001967 | suckling behavior | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 1 | 10 |
GO:0008143 | poly(A) binding | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 2 | 10 |
GO:0051131 | chaperone-mediated protein complex assembly | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 3 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 4 | 11 |
GO:0006479 | protein methylation | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 2 | 11 |
GO:0008334 | histone mRNA metabolic process | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 11 |
GO:0017025 | TBP-class protein binding | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 12 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.57e-02 | 1.00e+00 | 2.208 | 3 | 17 | 317 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 1 | 13 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 1 | 14 |
GO:0043393 | regulation of protein binding | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 2 | 14 |
GO:0016575 | histone deacetylation | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 2 | 14 |
GO:0004177 | aminopeptidase activity | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 3 | 14 |
GO:0008135 | translation factor activity, nucleic acid binding | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 4 | 15 |
GO:0070932 | histone H3 deacetylation | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 15 |
GO:0005730 | nucleolus | 3.06e-02 | 1.00e+00 | 1.267 | 6 | 74 | 1217 |
GO:0003887 | DNA-directed DNA polymerase activity | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 2 | 16 |
GO:0044267 | cellular protein metabolic process | 3.36e-02 | 1.00e+00 | 2.057 | 3 | 14 | 352 |
GO:0043022 | ribosome binding | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 2 | 17 |
GO:0031047 | gene silencing by RNA | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 18 |
GO:0006378 | mRNA polyadenylation | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 3 | 18 |
GO:0005634 | nucleus | 3.67e-02 | 1.00e+00 | 0.726 | 11 | 158 | 3246 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 1 | 19 |
GO:0006913 | nucleocytoplasmic transport | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 2 | 20 |
GO:0071346 | cellular response to interferon-gamma | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 2 | 20 |
GO:0034660 | ncRNA metabolic process | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 1 | 20 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 2 | 21 |
GO:0051084 | 'de novo' posttranslational protein folding | 4.41e-02 | 1.00e+00 | 4.472 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 4.41e-02 | 1.00e+00 | 4.472 | 1 | 1 | 22 |
GO:0001103 | RNA polymerase II repressing transcription factor binding | 4.61e-02 | 1.00e+00 | 4.408 | 1 | 2 | 23 |
GO:0016071 | mRNA metabolic process | 4.66e-02 | 1.00e+00 | 2.522 | 2 | 10 | 170 |
GO:0006370 | 7-methylguanosine mRNA capping | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 6 | 24 |
GO:0030901 | midbrain development | 5.00e-02 | 1.00e+00 | 4.288 | 1 | 1 | 25 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 5.00e-02 | 1.00e+00 | 4.288 | 1 | 3 | 25 |
GO:0006412 | translation | 5.06e-02 | 1.00e+00 | 2.456 | 2 | 12 | 178 |
GO:0004842 | ubiquitin-protein transferase activity | 5.12e-02 | 1.00e+00 | 2.448 | 2 | 17 | 179 |
GO:0030145 | manganese ion binding | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 3 | 26 |
GO:0009267 | cellular response to starvation | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 1 | 26 |
GO:0005057 | receptor signaling protein activity | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 2 | 26 |
GO:0016032 | viral process | 5.48e-02 | 1.00e+00 | 1.775 | 3 | 30 | 428 |
GO:0016070 | RNA metabolic process | 5.58e-02 | 1.00e+00 | 2.377 | 2 | 10 | 188 |
GO:0050885 | neuromuscular process controlling balance | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 1 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 5.78e-02 | 1.00e+00 | 4.073 | 1 | 4 | 29 |
GO:0042752 | regulation of circadian rhythm | 5.78e-02 | 1.00e+00 | 4.073 | 1 | 5 | 29 |
GO:0006446 | regulation of translational initiation | 5.78e-02 | 1.00e+00 | 4.073 | 1 | 2 | 29 |
GO:0005737 | cytoplasm | 6.33e-02 | 1.00e+00 | 0.739 | 9 | 127 | 2633 |
GO:0015030 | Cajal body | 6.36e-02 | 1.00e+00 | 3.931 | 1 | 3 | 32 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 6.39e-02 | 1.00e+00 | 1.684 | 3 | 29 | 456 |
GO:0017148 | negative regulation of translation | 6.55e-02 | 1.00e+00 | 3.887 | 1 | 5 | 33 |
GO:0007254 | JNK cascade | 6.74e-02 | 1.00e+00 | 3.844 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 5 | 35 |
GO:0044297 | cell body | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 5 | 35 |
GO:0030900 | forebrain development | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 2 | 36 |
GO:0003743 | translation initiation factor activity | 7.32e-02 | 1.00e+00 | 3.722 | 1 | 8 | 37 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 7.51e-02 | 1.00e+00 | 3.684 | 1 | 4 | 38 |
GO:0048511 | rhythmic process | 7.51e-02 | 1.00e+00 | 3.684 | 1 | 5 | 38 |
GO:0003684 | damaged DNA binding | 8.08e-02 | 1.00e+00 | 3.574 | 1 | 1 | 41 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 8.27e-02 | 1.00e+00 | 3.539 | 1 | 1 | 42 |
GO:0001047 | core promoter binding | 8.27e-02 | 1.00e+00 | 3.539 | 1 | 4 | 42 |
GO:0001570 | vasculogenesis | 8.83e-02 | 1.00e+00 | 3.440 | 1 | 2 | 45 |
GO:0008203 | cholesterol metabolic process | 9.21e-02 | 1.00e+00 | 3.377 | 1 | 2 | 47 |
GO:0007626 | locomotory behavior | 9.21e-02 | 1.00e+00 | 3.377 | 1 | 1 | 47 |
GO:0001558 | regulation of cell growth | 9.58e-02 | 1.00e+00 | 3.317 | 1 | 2 | 49 |
GO:0006310 | DNA recombination | 9.77e-02 | 1.00e+00 | 3.288 | 1 | 8 | 50 |
GO:0005524 | ATP binding | 1.03e-01 | 1.00e+00 | 1.131 | 4 | 37 | 892 |
GO:0008584 | male gonad development | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 1 | 57 |
GO:0000785 | chromatin | 1.14e-01 | 1.00e+00 | 3.049 | 1 | 6 | 59 |
GO:0006464 | cellular protein modification process | 1.18e-01 | 1.00e+00 | 3.001 | 1 | 4 | 61 |
GO:0003677 | DNA binding | 1.22e-01 | 1.00e+00 | 1.044 | 4 | 52 | 947 |
GO:0006415 | translational termination | 1.22e-01 | 1.00e+00 | 2.954 | 1 | 2 | 63 |
GO:0030018 | Z disc | 1.23e-01 | 1.00e+00 | 2.931 | 1 | 3 | 64 |
GO:0006364 | rRNA processing | 1.29e-01 | 1.00e+00 | 2.865 | 1 | 2 | 67 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 1.29e-01 | 1.00e+00 | 2.865 | 1 | 5 | 67 |
GO:0030308 | negative regulation of cell growth | 1.34e-01 | 1.00e+00 | 2.802 | 1 | 3 | 70 |
GO:0051082 | unfolded protein binding | 1.34e-01 | 1.00e+00 | 2.802 | 1 | 5 | 70 |
GO:0010951 | negative regulation of endopeptidase activity | 1.36e-01 | 1.00e+00 | 2.782 | 1 | 2 | 71 |
GO:0001889 | liver development | 1.36e-01 | 1.00e+00 | 2.782 | 1 | 4 | 71 |
GO:0016363 | nuclear matrix | 1.39e-01 | 1.00e+00 | 2.742 | 1 | 10 | 73 |
GO:0051726 | regulation of cell cycle | 1.39e-01 | 1.00e+00 | 2.742 | 1 | 3 | 73 |
GO:0005829 | cytosol | 1.44e-01 | 1.00e+00 | 0.713 | 6 | 88 | 1787 |
GO:0005739 | mitochondrion | 1.49e-01 | 1.00e+00 | 1.152 | 3 | 32 | 659 |
GO:0042127 | regulation of cell proliferation | 1.52e-01 | 1.00e+00 | 2.610 | 1 | 4 | 80 |
GO:0042802 | identical protein binding | 1.63e-01 | 1.00e+00 | 1.464 | 2 | 15 | 354 |
GO:0008201 | heparin binding | 1.71e-01 | 1.00e+00 | 2.424 | 1 | 4 | 91 |
GO:0000209 | protein polyubiquitination | 1.73e-01 | 1.00e+00 | 2.408 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.73e-01 | 1.00e+00 | 2.408 | 1 | 6 | 92 |
GO:0006260 | DNA replication | 1.76e-01 | 1.00e+00 | 2.377 | 1 | 9 | 94 |
GO:0045893 | positive regulation of transcription, DNA-templated | 1.79e-01 | 1.00e+00 | 1.373 | 2 | 21 | 377 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.81e-01 | 1.00e+00 | 2.332 | 1 | 7 | 97 |
GO:0006457 | protein folding | 1.81e-01 | 1.00e+00 | 2.332 | 1 | 5 | 97 |
GO:0006413 | translational initiation | 1.85e-01 | 1.00e+00 | 2.302 | 1 | 6 | 99 |
GO:0006397 | mRNA processing | 2.03e-01 | 1.00e+00 | 2.150 | 1 | 12 | 110 |
GO:0042981 | regulation of apoptotic process | 2.06e-01 | 1.00e+00 | 2.124 | 1 | 4 | 112 |
GO:0042803 | protein homodimerization activity | 2.18e-01 | 1.00e+00 | 1.190 | 2 | 13 | 428 |
GO:0016020 | membrane | 2.28e-01 | 1.00e+00 | 0.694 | 4 | 56 | 1207 |
GO:0016874 | ligase activity | 2.60e-01 | 1.00e+00 | 1.742 | 1 | 11 | 146 |
GO:0001701 | in utero embryonic development | 2.73e-01 | 1.00e+00 | 1.665 | 1 | 7 | 154 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.83e-01 | 1.00e+00 | 1.601 | 1 | 18 | 161 |
GO:0005874 | microtubule | 2.86e-01 | 1.00e+00 | 1.583 | 1 | 10 | 163 |
GO:0007067 | mitotic nuclear division | 2.89e-01 | 1.00e+00 | 1.565 | 1 | 9 | 165 |
GO:0046872 | metal ion binding | 2.98e-01 | 1.00e+00 | 0.649 | 3 | 24 | 934 |
GO:0003713 | transcription coactivator activity | 3.17e-01 | 1.00e+00 | 1.408 | 1 | 21 | 184 |
GO:0016567 | protein ubiquitination | 3.22e-01 | 1.00e+00 | 1.377 | 1 | 14 | 188 |
GO:0005743 | mitochondrial inner membrane | 3.35e-01 | 1.00e+00 | 1.309 | 1 | 9 | 197 |
GO:0005525 | GTP binding | 3.35e-01 | 1.00e+00 | 1.309 | 1 | 12 | 197 |
GO:0035556 | intracellular signal transduction | 3.38e-01 | 1.00e+00 | 1.295 | 1 | 5 | 199 |
GO:0008134 | transcription factor binding | 3.52e-01 | 1.00e+00 | 1.224 | 1 | 10 | 209 |
GO:0019899 | enzyme binding | 3.53e-01 | 1.00e+00 | 1.217 | 1 | 7 | 210 |
GO:0030054 | cell junction | 3.64e-01 | 1.00e+00 | 1.163 | 1 | 5 | 218 |
GO:0007165 | signal transduction | 3.64e-01 | 1.00e+00 | 0.660 | 2 | 24 | 618 |
GO:0030198 | extracellular matrix organization | 3.68e-01 | 1.00e+00 | 1.144 | 1 | 7 | 221 |
GO:0007186 | G-protein coupled receptor signaling pathway | 3.78e-01 | 1.00e+00 | 1.092 | 1 | 4 | 229 |
GO:0019901 | protein kinase binding | 3.82e-01 | 1.00e+00 | 1.073 | 1 | 8 | 232 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.84e-01 | 1.00e+00 | 0.601 | 2 | 29 | 644 |
GO:0008283 | cell proliferation | 3.91e-01 | 1.00e+00 | 1.031 | 1 | 8 | 239 |
GO:0006508 | proteolysis | 4.22e-01 | 1.00e+00 | 0.887 | 1 | 11 | 264 |
GO:0046982 | protein heterodimerization activity | 4.24e-01 | 1.00e+00 | 0.882 | 1 | 11 | 265 |
GO:0043565 | sequence-specific DNA binding | 4.36e-01 | 1.00e+00 | 0.828 | 1 | 8 | 275 |
GO:0006355 | regulation of transcription, DNA-templated | 4.36e-01 | 1.00e+00 | 0.450 | 2 | 31 | 715 |
GO:0008285 | negative regulation of cell proliferation | 4.38e-01 | 1.00e+00 | 0.818 | 1 | 11 | 277 |
GO:0070062 | extracellular vesicular exosome | 4.40e-01 | 1.00e+00 | 0.251 | 4 | 51 | 1641 |
GO:0008284 | positive regulation of cell proliferation | 4.40e-01 | 1.00e+00 | 0.807 | 1 | 8 | 279 |
GO:0008270 | zinc ion binding | 4.45e-01 | 1.00e+00 | 0.426 | 2 | 39 | 727 |
GO:0009986 | cell surface | 4.54e-01 | 1.00e+00 | 0.747 | 1 | 5 | 291 |
GO:0000278 | mitotic cell cycle | 4.80e-01 | 1.00e+00 | 0.637 | 1 | 28 | 314 |
GO:0048471 | perinuclear region of cytoplasm | 5.12e-01 | 1.00e+00 | 0.505 | 1 | 11 | 344 |
GO:0005783 | endoplasmic reticulum | 5.49e-01 | 1.00e+00 | 0.358 | 1 | 12 | 381 |
GO:0006915 | apoptotic process | 5.77e-01 | 1.00e+00 | 0.248 | 1 | 15 | 411 |
GO:0006351 | transcription, DNA-templated | 6.64e-01 | 1.00e+00 | -0.140 | 2 | 47 | 1076 |
GO:0005887 | integral component of plasma membrane | 7.03e-01 | 1.00e+00 | -0.236 | 1 | 8 | 575 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 7.08e-01 | 1.00e+00 | -0.253 | 1 | 22 | 582 |
GO:0005886 | plasma membrane | 9.03e-01 | 1.00e+00 | -0.869 | 2 | 46 | 1784 |
GO:0016021 | integral component of membrane | 9.67e-01 | 1.00e+00 | -1.644 | 1 | 19 | 1526 |